This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Norman M. Kaplan, MD
University of Texas Southwestern Medical Center at Dallas

JAMA. 1996;275(7):518.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—On August 19, 1995, I was asked by a public relations firm to compose a letter to respond to the forthcoming publication of the article by Dr Psaty and colleagues.¹ Having been greatly disturbed by the one-sided, sensational handling by the press of the oral report of these data in March 1995, I readily agreed to do so. As I explained to Dr Lurie when he called on September 11,1995,I did not ask who was sponsoring the letter and only later discovered that it was Bayer Corporation. I neither asked for nor received any compensation. I was assured that if there was a need for identification of corporate sponsorship, it would be included.

I regret that the corporate sponsorship was not included but I stand by every word of my letter. My letter was not "misleading because it omitted pertinent information and other evidence calling the safety . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?